Rad/Molecular Imaging Program at Stanford
Showing 1-68 of 68 Results
-
Israt Alam
Senior Research Scientist-Basic Life, Rad/Molecular Imaging Program at Stanford
BioResearch Focus and interests: Molecular Imaging, Clinical Translation, Graft versus Host Disease, Spatial Biology, Immune-Theragnostics
Dr. Israt Alam is a Senior Scientist in the Radiology Department at Stanford University. She trained in Prof. Sanjiv Sam Gambhir's lab and transitioned to Dr. Michelle James' lab in 2021. Her research focuses on studying lymphocyte activation and developing non-invasive imaging tools, to monitor immune dynamics in response to cancer immunotherapy and in immunopathology. Her work has supported the clinical translation of several nuclear imaging agents (small molecules and a biologic) for early detection of cancer and prediction of treatment response, that are being evaluated in oncology trials around the world. She is currently leading the IND-enabling studies for a first in class PET tracer for T cell activation and has supported several biomarker detection platforms for early disease detection. She serves as Co-Chair of the "Imaging in cell and immune therapies" (ICIT) interest group for the World Molecular Imaging Society (WMIS).
Key funding: (grant conceptualization/scientific lead): NIH/NCI R01, Pfizer Inc., SNMMI Education and Research Foundation
Appointments:
-Senior Research Scientist, James Lab, Department of Radiology, Stanford
-Life Sciences Research Associate, Gambhir Lab, Department of Radiology, Stanford
-Post-Doctoral Scholar, Gambhir Lab, Department of Radiology, Stanford
-Churchill Travel Fellow in the Plateforme d'imagerie dynamique lab of Prof. Spencer Shorte, Pasteur Institute, Paris
-Science Education Consultant: United Nations Educational, Science and Cultural Organization (UNESCO), Paris
-Science Education Intern: United Nations Educational, Science and Cultural Organization (UNESCO), Paris -
David Anders
Director of Research, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordDirector of the Cyclotron and Radiochemistry Facility
The CRF team is excited to be designing our second cyclotron facility where we will expand production into radiometals. -
Vikram S Bajaj
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioAdj. Professor, Stanford Radiology.
Managing Director, Foresite Capital Management
Co-Founder/CEO, Foresite Labs
Previous:
Chief Scientific Officer, GRAIL
Chief Scientific Officer and Co-Founder, Verily (Google Life Sciences) -
Corinne Beinat
Assistant Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
-
Edwin Chang
Director, Small Animal Imaging Facility at Porter Drive, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordDirector, SCI3@Porter or the Canary Core Preclinical Imaging Facility at Stanford
-
Meysam Dadgar
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioMeysam Dadgar is a Postdoctoral Research Fellow at the Molecular Imaging Program at Stanford University, School of Medicine. He obtained his Ph.D. in Biophysics from Jagiellonian University in Kraków, Poland, as part of the J-PET collaboration, and previously held a Postdoctoral Fellowship at Ghent University, Belgium.
Dr. Dadgar’s research focuses on the development and optimization of next-generation positron emission tomography (PET) systems for cancer detection and precision medicine. His expertise spans PET instrumentation, Monte Carlo and GATE simulations, advanced image reconstruction, and AI-based image enhancement. He has made significant contributions to the design and evaluation of novel PET geometries, including dual-panel and total-body PET, as well as positronium imaging approaches that extend beyond conventional PET capabilities.
In addition to his PET-focused research, Dr. Dadgar gained unique experience at CERN, where he worked on advanced detector development, including trigger electronics, PET coincidence measurements, and composite material production under controlled conditions. These experiences provided him with a strong foundation in detector design, fabrication, and calibration that complements his biomedical imaging research.
He has authored more than 20 peer-reviewed publications, including papers in Science Advances, Nature Communications, IEEE Transactions on Radiation and Plasma Medical Sciences, and EJNMMI Physics. He has been recognized with multiple international fellowships and awards, including IEEE NSS/MIC Trainee Grants and national research grants in Europe.
At Stanford, Dr. Dadgar’s work integrates state-of-the-art medical imaging technologies, particle physics methods, and AI-driven modeling to improve sensitivity, resolution, and diagnostic accuracy in PET, with the ultimate goal of advancing early cancer detection and patient care. -
Jennifer Dionne
Professor of Materials Science and Engineering, Senior Fellow at the Precourt Institute for Energy and Professor, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
BioJennifer (Jen) Dionne is a Professor of Materials Science and Engineering and, by courtesy, of Radiology at Stanford. She is also a Chan Zuckerberg Biohub Investigator, deputy director of Q-NEXT (a DOE National Quantum Initiative), and co-founder of Pumpkinseed, a company developing quantum sensors to understand and optimize the immune system. From 2020-2023, Jen served as Stanford’s Inaugural Vice Provost of Shared Facilities, raising capital to modernize instrumentation, fund experiential education, foster staff development, and support new and existing users of the shared facilities. Jen received her B.S. degrees in Physics and Systems Science and Mathematics from Washington University in St. Louis, her Ph. D. in Applied Physics at the California Institute of Technology in 2009, and her postdoctoral training in Chemistry at Berkeley. As a pioneer of nanophotonics, she is passionate about developing methods to observe and control chemical and biological processes as they unfold with nanometer scale resolution, emphasizing critical challenges in global health and sustainability. Her research has developed culture-free methods to detect pathogens and their antibiotic susceptibility; amplification-free methods to detect and sequence nucleic acids and proteins; and new methods to image light-driven chemical reactions with atomic-scale resolution. Jen’s work has been featured in NPR, the Economist, Science, and Nature, and recognized with the NSF Alan T. Waterman Award, a NIH Director’s New Innovator Award, a Moore Inventor Fellowship, and the Presidential Early Career Award for Scientists and Engineers. She was also featured on Oprah’s list of “50 Things that will make you say ‘Wow’!”. She also perceives outreach as a critical component of her role and frequently collaborates with visual and performing artists to convey the beauty of science to the broader public.
-
Gozde Durmus
Assistant Professor (Research) of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsDr. Durmus' research focuses on applying micro/nano-technologies to investigate cellular heterogeneity for single-cell analysis and personalized medicine. At Stanford, she is developing platform technologies for sorting and monitoring cells at the single-cell resolution. This magnetic levitation-based technology is used for wide range of applications in medicine, such as, label-free detection of circulating tumor cells (CTCs) from blood; high-throughput drug screening; and rapid detection and monitoring of antibiotic resistance in real-time. During her PhD, she has engineered nanoparticles and nanostructured surfaces to decrease antibiotic-resistant infections.
-
Katherine Ferrara
Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsMy focus is image-guided drug and gene delivery and I am engaged in the design of imaging devices, molecularly-targeted imaging probes and engineered delivery vehicles, drawing upon my education in biology and imaging physics and more than 20 years of experience with the synthesis and labeling of therapeutic particles. My laboratory has unique resources for and substantial experience in synthetic chemistry and ultrasound, CT, MR and PET imaging.
-
Edward Graves
Professor of Radiation Oncology (Radiation Physics), and by courtesy, of Radiology
Current Research and Scholarly InterestsApplications of molecular imaging in radiation therapy, small animal image-guided conformal radiotherapy, immune responses to radiation, immunotherapy and radiotherapy combinations, image processing and analysis.
-
Frezghi Habte
Director, Stanford Center for Innovations in In vivo Imaging (SCi3), Stanford Center for Innovation and In Vivo Imaging
Current Role at StanfordDirector, Stanford Center for Innovation, in In vivo Imaging
-
Michelle L. James
Associate Professor of Radiology (Molecular Imaging Program at Stanford) and of Neurology and Neurological Sciences (Neurology Research)
Current Research and Scholarly InterestsThe primary aim of my lab is to improve the diagnosis and treatment of brain diseases by developing translational molecular imaging agents for visualizing neuroimmune interactions underlying conditions such as Alzheimer’s disease, multiple sclerosis, and stroke.
-
Jorgen Arendt Jensen
Visiting Professor, Radiology - Rad/Molecular Imaging Program at Stanford
BioI am a professor of Biomedical Signal Processing at the Department of Health Technology (DTU Health), Technical University of Denmark (www.dtu.dk). My main interests are the application of digital signal processing to medical ultrasound, especially synthetic aperture imaging, vector flow imaging, super-resolution, GPU-based beamforming and implementation, and ultrasound simulation.
I received the M.Sc. in electrical engineering in 1985, the Ph.D. in 1989 for work on deconvolution, and the Dr. Techn. degree in 1996 for my work on blood velocity estimation in the book: "Estimation of Blood Velocities Using Ultrasound, A Signal Processing Approach", which was published by Cambridge University Press in 1996. I have been a full professor at DTU since 1993, and I have been a visiting scientist at Duke University, North Carolina, Stanford University, California, and the University of Illinois at Urbana-Champaign, all in the US. I became an IEEE Fellow in 2012.
I have founded and headed the Center for Fast Ultrasound Imaging (www.cfu.dtu.dk) since 1998. Currently, I am a visiting Professor in the Department of Radiology at Stanford University, CA, USA, courtesy of Professors Katherine Ferrara and Jeremy Dahl, until August 2026. I will be working here on our super-resolution method, SURE, using the Stanford large-element arrays for the acquisition of clinical data. I am also writing a book on advanced ultrasound imaging, drawing on my 40 years in the field.
Link to home page: https://home.healthtech.dtu.dk/jaj/, which has a publication list. -
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioDr. Jeff Kleck
Current Roles
Adjunct Professor, Stanford University School of Medicine — Stanford, California
Senior Partner, Eleven of Ten (Elevens) — Menlo Park, California
Chairman, Open Power & Energy Network (OPEN) — Washington, District of Columbia
Senior Advisor, United States Department of War (US DoW) — Pentagon, Arlington, Virginia
Previous Academic Appointments
Dean of Academics, Catholic Institute of Technology (CIT) — Cambridge, Massachusetts & Castel Gandolfo, Italy
Adjunct Associate Professor, University of California, Los Angeles (UCLA)
Visiting Scientist, Lawrence Berkeley National Laboratory (LBNL)
Visiting Scientist, Los Alamos National Laboratory (LANL)
Previous Commercial Technology Ventures
President and Board Member, Rapid AI
Founder, CEO, and Chairman of the Board, Attainia
Founder, CEO, and Chairman of the Board, Neoforma
Previous Government Service
Senior Advisor, United States Department of Defense (US DoD)
Director, Defense Innovation Unit (DIU), United States Department of Defense (US DoD)
Education
Ph.D., Biomedical Physics, University of California, Los Angeles (UCLA)
M.S., Engineering Management, Stanford University, Stanford
M.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
B.S., Nuclear Engineering, Texas A&M University, College Station (TAMU)
St. John's University, Collegeville (SJU)
The University of Texas, Austin (UT)
Awards in Current Roles
Ukraine Foreign Military Medal, bestowed by the Commander of the Ukraine Armed Forces (2023)
U.S. Department of Defense Award for Team Cyber & IT Excellence, bestowed by the US DoD Chief Information Officer (2019) -
Jason Thanh Lee
Deputy Director, Molecular Imaging Program, Rad/Molecular Imaging Program at Stanford
BioBiomedical imaging scientist in preclinical molecular and nuclear imaging, particularly employing PET, CT and optical techniques. Applications include therapeutic development, oncology, immunotherapy, neuroscience, and molecular biology. Active in translational diagnostics research and development. Broad foundation in molecular biology assays and in vivo disease models.
-
Craig Levin
Professor of Radiology (Molecular Imaging Program at Stanford/Nuclear Medicine) and, by courtesy, of Physics, of Electrical Engineering and of Bioengineering
Current Research and Scholarly InterestsMolecular Imaging Instrumentation
Laboratory
Our research interests involve the development of novel instrumentation and software algorithms for in vivo imaging of cellular and molecular signatures of disease in humans and small laboratory animal subjects. -
Rim Malek
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsMy work is focused on the development of small molecules radiotracers for cancer imaging, and small molecules and peptides theranostics for cancer detection, targeted radionuclide therapy, and monitoring of tumor response to therapy.
-
Noeen Malik, PhD
Industry Partnership Lead, Operations CRF-1701 Page Mill Rd, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordOperations Head (CRF-Page Mill Facility)
CRF, MIPS, Stanford School of Medicine, Stanford | February 2025 — present
Industry Partnership Lead
CRF, MIPS, Stanford School of Medicine, Stanford | May 2024 — present
Lead Radiochemist (R & D Scientist Engineer 2)
CRF, MIPS, Stanford School of Medicine, Stanford | March 2023 — present
Physical Science Research Scientist
CRF, MIPS, Stanford School of Medicine, Stanford | January 2022 — March 2023
Responsibilities:
• Overseeing operations of new Page Mill Road Facilty (CRF-1701 Page Mill)
• R & D of radiopharmaceuticals for oncology and neuroscience
• Industrial collaborations and partnerships
• Drafting and filing drug applications with regulatory agencies (CMCs, INDs)
• Documentation control for audits and in compliance with FDA, Boards of Pharmacy, USP, NRC, and PET CGMP standards.
• Market strategic report for theragnostic-isotopes for Nextgen Cyclotron project
• CRF website development
https://cyclotron.stanford.edu/ -
Arutselvan Natarajan
Senior Research Scientist - Basic Life, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Scientist
-
Jun Hyung Park
Research and Development Science and Engineer 1, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordI joined in Cyclotron and radiochemstry facility in 2014. I focus on routine radiopharmaceutical production, including 18F tracers (18F-Flumazenil, 18F-FTC-146, 18F-FLT, 18F Arag, 18F-FSPG etc.); 11C tracers (11C UCB-J, 11C-raclopride, 11C-PIB, 11C-methionine, 11C DPA-713 etc.); 15O-H2O and 68Ga-DOTATATE radiochemistry for clinical use and supporting various of pre-clinical studies.
-
Shirin Pourashraf
Physical Science Research Scientist, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordStaff - Physical Science Research Scientist, Academic Staff at Rad/Molecular Imaging Program at Stanford
-
Jianghong Rao
Professor of Radiology (Molecular Imaging Program at Stanford) and, by courtesy, of Chemistry
Current Research and Scholarly InterestsProbe chemistry and nanotechnology for molecular imaging and diagnostics
-
Samantha Reyes
Postdoctoral Scholar, Molecular Imaging Program at Stanford
BioResearch Interests: Preclinical and clinical PET imaging, novel tracer validation in vivo, neuroinflammation, proteomics, theranostics and pharmacokinetic modeling
Samantha is an NIH T32 SMIS Postdoctoral Scholar who completed her PhD in Biomedical Physics in Dr. Michelle James' laboratory at Stanford, where her doctoral work focused on the development and translational validation of novel PET radiotracers for non-invasive imaging of neuroinflammation. She led the preclinical development and validation of two GPR84-targeted PET radiotracers for imaging innate immune activation in a murine model of multiple sclerosis, and also led the clinical data analysis for the first whole-body TSPO-PET/MRI study in female patients with ME/CFS. She is well-versed in preclinical and clinical PET quantitation, pharmacokinetic modeling, autoradiography, and cell-based assays. Her postdoctoral research applies her molecular imaging expertise to gynecological cancers, with a focus on using proteomics-driven biomarker discovery and novel theranostic radioligands to characterize the tumor microenvironment and improve response to therapy in women's cancer. -
George Segall
Professor of Radiology, Emeritus
Current Research and Scholarly InterestsScintigraphic evaluation of coronary blood flow and myocardial function using single photon emission computed tomography (SPECT) and positron emission tomography (PET). Tumor imaging and characterization of pulmonary nodules with PET/CT.
-
Shan X. Wang
Leland T. Edwards Professor in the School of Engineering and Professor of Electrical Engineering and, by courtesy, of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsShan Wang was named the Leland T. Edwards Professor in the School of Engineering in 2018. He directs the Center for Magnetic Nanotechnology and is a leading expert in Edge AI, biosensors, information storage and spintronics. His research and inventions span across a variety of areas including Edge AI, magnetic biochips, in vitro diagnostics, cancer biomarkers, magnetic nanoparticles, magnetic sensors, magnetoresistive random access memory, and magnetic integrated inductors.
-
Zhen Xiao
Postdoctoral Scholar, Molecular Imaging Program at Stanford
Current Research and Scholarly InterestsApplying magnetic nanomaterials for bioimaging and cancer treatment
